Amgen : AMGN

All Amgen Articles

708 Articles

Lee Jackson | Nov 6, 2013 at 8:30 AM EST

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

ThinkstockThe UBS proprietary institutional flow data indicates that hedge funds are increasing exposure to financials and decreasing exposure to health…

Jon C. Ogg | Oct 21, 2013 at 11:10 AM EDT

The Top 14 Earnings to Watch This Week

Jon OggThe S&P 500 Index is hitting all-time highs and we are now deep into earnings season. This week will…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

Lee Jackson | Oct 3, 2013 at 11:50 AM EDT

Top Biotechs Set to Win in the War on Cancer

ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Aug 26, 2013 at 1:29 PM EDT

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Any time you see a merger announcement, you see a myriad of press releases pertaining to law firms and lawyers…

Jon C. Ogg | Aug 26, 2013 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: 3D, Hasbro, Dollar Tree, Tyson and More

Jon OggThis will be an interesting week for Wall Street analyst coverage as many traders, investors and analysts are out…

Jon C. Ogg | Aug 26, 2013 at 8:05 AM EDT

Lessons of Buying Growth Companies Doubling Their Revenues

ThinkstockAmgen Inc. (NASDAQ: AMGN) wants to regain its status as the largest publicly traded biotech in the U.S. The company formalized…

Jon C. Ogg | Aug 1, 2013 at 8:25 AM EDT

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

ThinkstockWith the Federal Reserve reminding investors yesterday that it can raise or lower asset purchases in its quantitative easing program…

Paul Ausick | Jul 31, 2013 at 4:25 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

July 31, 2013: U.S. equity markets opened higher this morning as traders and investors this afternoon’s announcement from the FOMC.…

Paul Ausick | Jul 30, 2013 at 4:07 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the…

Jon C. Ogg | Jul 23, 2013 at 8:25 AM EDT

UBS Top Stocks to Buy That Can Beat Earnings Estimates

courtesy of FordThe equity analysts and strategists at UBS A.G. (NYSE: UBS) expect to see U.S. equities continue to conform…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

1 … 31 32 33 34 35 … 48

Amgen : AMGN

All Amgen Articles

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

The Top 14 Earnings to Watch This Week

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Top Analyst Upgrades and Downgrades: 3D, Hasbro, Dollar Tree, Tyson and More

Lessons of Buying Growth Companies Doubling Their Revenues

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

UBS Top Stocks to Buy That Can Beat Earnings Estimates

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

Amgen : AMGN

All Amgen Articles

UBS Sees Hedge Funds Selling Health Care and Buying Financial and Energy Stocks

The Top 14 Earnings to Watch This Week

Jefferies Top Biotech Stocks to Buy

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Biotechs Set to Win in the War on Cancer

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Top Analyst Upgrades and Downgrades: 3D, Hasbro, Dollar Tree, Tyson and More

Lessons of Buying Growth Companies Doubling Their Revenues

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

UBS Top Stocks to Buy That Can Beat Earnings Estimates

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

If Social Security Cuts Benefits, Here’s Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account

AI Architect Earning $1.1M/Year Almost Took on $550K in Debt to Dodge Taxes: ‘I Have No Idea What That Business Is’

Featured Reads

If Social Security Cuts Benefits, Here's Who Might Get Hurt the Most

Peter Thiel Turned a $2,000 Roth IRA Into $5 Billion and Will Never Owe a Penny of Tax. The Same Rules Apply to Your Account